News
Curium strikes $8bn deal to buy radiopharma rival Lantheus
Two players in the radiopharma sector, Curium and Lantheus, have agreed to merge and create an end-to-end player in diagnostics and therapeutics.
Oncology
Key lessons from EHA 2026: Translating evidence into impact
Across four days in Sweden, EHA 2026 offered a clear view of the future of blood cancer care.
News
Datroway joins Trodelvy for frontline TNBC in the EU
AstraZeneca and Daiichi Sankyo's Datroway enters the first-line triple-negative breast cancer market in the EU, taking on Gilead's Trodelvy.
News
Adcomm backs Replimune melanoma drug, despite data concern
Replimune's RP1 immunotherapy for melanoma clears advisory committee vote by 10 to three, despite FDA concerns about the design of the IGNYTE study.
News
UK patient first in world to get novel lung cancer vaccine
A woman from the Wirral in the UK has become the first patient in the world to receive an experimental, personalised lung cancer vaccine.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
